More on WAT
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $455.59 |
|
|||
| Open | $458.16 | ||||
| 52 Wk High | $162.53 | ||||
| 52 Wk Low | $112.00 | ||||
| Day High | $458.16 | ||||
| Day Low | $446.70 | ||||
| P/E | 87.24 | ||||
| EPS | $5.20 | ||||
| Volume | 907,607 | ||||
- Waters and Labcorp partner to offer FDA-approved HPV test by end of 2026
- Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026
- Waters Corporation and Quest Diagnostics Help Close Cervical Cancer Screening Gap Bringing Nationwide Access to the Most Comprehensive FDA-Cleared At-Home HPV Screening Option
- IMU and UK Biobank to generate the world’s most detailed, large-scale picture of the human immune system for advancing research into health and disease
- Waters Corp. (WAT) PT Raised to $515 at TD Cowen
- Waters Corporation launches AI Link software with Anthropic integration
- Waters Launches AI Link, Advancing AI-Enabled LC-MS Workflows from Research to Release
- Waters Corp. (WAT) PT Raised to $495 at Baird
- Waters Corp. (WAT) PT Raised to $500 at Barclays
- KeyBanc's Preview of 'Biggest Potential Beats in Life Science'
Entities mentioned with WAT
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- 13G | View Related Stories »
- Show More...
